GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Wanjia Group Holdings Ltd (HKSE:00401) » Definitions » EBITDA Margin %

Wanjia Group Holdings (HKSE:00401) EBITDA Margin % : -2.14% (As of Sep. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Wanjia Group Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Wanjia Group Holdings's EBITDA for the six months ended in Sep. 2023 was HK$-2.0 Mil. Wanjia Group Holdings's Revenue for the six months ended in Sep. 2023 was HK$93.4 Mil. Therefore, Wanjia Group Holdings's EBITDA margin for the quarter that ended in Sep. 2023 was -2.14%.


Wanjia Group Holdings EBITDA Margin % Historical Data

The historical data trend for Wanjia Group Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanjia Group Holdings EBITDA Margin % Chart

Wanjia Group Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.52 -2.25 7.15 -22.37 9.44

Wanjia Group Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.41 -58.05 -1.28 6.73 -2.14

Competitive Comparison of Wanjia Group Holdings's EBITDA Margin %

For the Medical Distribution subindustry, Wanjia Group Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanjia Group Holdings's EBITDA Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Wanjia Group Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Wanjia Group Holdings's EBITDA Margin % falls into.



Wanjia Group Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Wanjia Group Holdings's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=16.396/173.702
=9.44 %

Wanjia Group Holdings's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-1.994/93.373
=-2.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanjia Group Holdings  (HKSE:00401) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Wanjia Group Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Wanjia Group Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanjia Group Holdings (HKSE:00401) Business Description

Traded in Other Exchanges
N/A
Address
25 Canton Road, Harbour City, Suite 1801, 18th Floor, Tower 1, The Gateway, Kowloon, Hong Kong, HKG
Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business.
Executives
Wang Jia Jun 2101 Beneficial owner
Expert Wealth Investments Limited 2201 Interest of corporation controlled by you
Grand Harbour Finance Limited 2106 Person having a security interest in shares
Yung Ka Lai 2101 Beneficial owner
Ng Kwok Fai 2201 Interest of corporation controlled by you
Wei Yang Tou Zi Fa Zhan You Xian Gong Si 2101 Beneficial owner
Li Wei 2202 Interest of your spouse
Liu Chang 2201 Interest of corporation controlled by you
Liu Yonghao 2201 Interest of corporation controlled by you
Nan Fang Xi Wang Shi Ye You Xian Gong Si 2201 Interest of corporation controlled by you
Xin Xi Wang Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Xi Zang Heng Ye Feng Shi Ye You Xian Gong Si 2201 Interest of corporation controlled by you

Wanjia Group Holdings (HKSE:00401) Headlines

No Headlines